How to work with a medtech CRO and stay in control

Most CROs were built for pharma. Medtech studies are smaller, faster-moving, and subject to different regulatory frameworks. When pharma-first tools and processes get forced into a medtech context, the friction shows up in lost bids, budget overruns, and sponsors who don't come back.

This webinar brings together two experienced medtech clinical professionals to talk honestly about what it takes to operate successfully in the medtech CRO space and what medtech companies need to know before they outsource any clinical work.

What we will cover:

• The CRO landscape in medtech and how it differs from pharma
• Choosing between in-house and outsourced clinical models
• What medtech companies need in-house before running any clinical study
• How to select the right CRO for a medtech study
• Compliance and regulatory nuances: ISO 14155 (International Organization for Standardization 14155), MDR vs pharma regulation
• Why pharma-first tools and playbooks can cost CROs medtech work
• How the right CRO eliminates sponsor surprises before they happen